Medgend Icon


Tirosint FDA Approved Drugs

LEVO-T [Levothyroxine SodiumC15H10I4NO4Na5H2O]
RX
-
0.025mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.075mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.088mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.125mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.137mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.15mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.175mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.1mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.2mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.3mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
Alara PharmMar 1, 2002
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LEVOTHYROXINE SODIUM [Levothyroxine SodiumC15H10I4NO4Na5H2O]
RX
-
0.025mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.075mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.088mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.125mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.137mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.15mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.175mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.1mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.2mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.3mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
100mcg/vial (intravenous powder)
200mcg/vial (intravenous powder)
500mcg/vial (intravenous powder)
MylanJun 5, 2002
Fera Pharms LlcJun 29, 2016
Fresenius Kabi UsaJun 24, 2011
Par Sterile ProductsDec 7, 2015
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

LEVOXYL [Levothyroxine SodiumC15H10I4NO4Na5H2O]
RX
-
0.025mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.075mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.088mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.125mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.137mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.15mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.175mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.1mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.2mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
King PharmsMay 25, 2001
  • Method of use of administering levothyroxine.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

SYNTHROID [Levothyroxine SodiumC15H10I4NO4Na5H2O]
RX
-
0.025mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.075mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.088mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.125mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.137mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.15mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.175mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.1mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.2mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.3mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
AbbvieJul 24, 2002
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TIROSINT [Levothyroxine SodiumC15H10I4NO4Na5H2O]
RX
-
0.013mg (oral capsule)
0.025mg (oral capsule)
0.05mg (oral capsule)
0.075mg (oral capsule)
0.088mg (oral capsule)
0.112mg (oral capsule)
0.125mg (oral capsule)
0.137mg (oral capsule)
0.15mg (oral capsule)
0.1mg (oral capsule)
Institut BiochimiqueAug 1, 2007
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

UNITHROID [Levothyroxine SodiumC15H10I4NO4Na5H2O]
RX
-
0.025mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.05mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.075mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.088mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.112mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.125mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.137mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.15mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.175mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.1mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.2mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
0.3mg **see current annual edition, 1.8 description of special situations, levothyroxine sodium (oral tablet)
Stevens JAug 21, 2000
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.